References
- Jung T, Vij N. Early diagnosis and real-time monitoring of regional lung function changes to prevent chronic obstructive pulmonary disease progression to severe emphysema. J Clin Med. 2021;10(24):5811. doi: 10.3390/jcm10245811
- Vij N. Synthesis and evaluation of airway-targeted PLGA-PEG nanoparticles for drug delivery in obstructive lung diseases. Methods Mol Biol. 2020;2118:147–154.
- Vij N, Min T, Bodas M, et al. Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases. Nanomedicine. 2016;12(8):2415–2427. doi: 10.1016/j.nano.2016.06.008
- Varshosaz J, Ghaffari S, Mirshojaei SF, et al. Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery. Biomed Res Int. 2013;2013:136859. doi: 10.1155/2013/136859
- Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124. doi: 10.1038/s41573-020-0090-8
- Kumar R, Mehta P, Shankar KR, et al. Nanotechnology-assisted metered-dose inhalers (MDIs) for high-performance pulmonary drug delivery applications. Pharm Res. 2022;39(11):2831–2855. doi: 10.1007/s11095-022-03286-y
- Forest V, Pourchez J. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient? Adv Drug Deliv Rev. 2022;183:114173. doi: 10.1016/j.addr.2022.114173
- Ngan CL, Asmawi AA. Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations. Drug Deliv Transl Res. 2018;8(5):1527–1544. doi: 10.1007/s13346-018-0550-4
- Ahmad J, Akhter S, Rizwanullah M, et al. Nanotechnology-based inhalation treatments for lung cancer: state of the art. Nanotechnol Sci Appl. 2015;8:55–66. doi: 10.2147/NSA.S49052
- Osman N, Kaneko K, Carini V, et al. Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies. Expert Opin Drug Deliv. 2018;15(8):821–834. doi: 10.1080/17425247.2018.1502267
- Zhong W, Zhang X, Zeng Y, et al. Recent applications and strategies in nanotechnology for lung diseases. Nano Res. 2021;14(7):2067–2089. doi: 10.1007/s12274-020-3180-3
- Moore C, Jokerst JV. Strategies for image-guided therapy, surgery, and drug delivery using photoacoustic imaging. Theranostics. 2019;9(6):1550–1571. doi: 10.7150/thno.32362
- Vij N. Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential. Expert Opinion On Drug Delivery. 2011;8(9):1105–1109. doi: 10.1517/17425247.2011.597381
- Vij N, Min T, Marasigan R, et al. Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis. J Nanobiotechnology. 2010;8(1):22. doi: 10.1186/1477-3155-8-22
- Roy I, Vij N. Nanodelivery in airway diseases: challenges and therapeutic applications. Nanomedicine. 2010;6(2):237–244. doi: 10.1016/j.nano.2009.07.001